凯杰生物 QGEN
$50.33 −$0.53 (-1.04%)
休市 · Nov 7, 9:50 pm ET · 最新盘后价 $50.40 +0.14%
开盘$50.42
昨收$50.86
当日区间$50.26 – $50.50
成交量3.39M
市值$10.39B
市盈率（TTM）27.7
股息率0.70%
QGEN 相关新闻
匹配 Qiagen NV 或代码 QGEN 的头条新闻，按最新排序。
- Deutsche Bank Maintains Qiagen NV(QGEN.US) With Buy Rating, Announces Target Price $53.46
- Berenberg Bank Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $45.5
- Morgan Stanley Maintains Qiagen NV(QGEN.US) With Buy Rating, Raises Target Price to $46.25 正面
- A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $45.5 to $46.09
- William Blair Maintains Qiagen NV(QGEN.US) With Hold Rating
- QIAGEN Appoints Jonathan M. Pratt As Chief Executive Officer QGEN
- J.P. Morgan Maintains Qiagen NV(QGEN.US) With Buy Rating, Announces Target Price $50
- Citi Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $45 正面
- Deutsche Bank Maintains Qiagen NV(QGEN.US) With Buy Rating
- Berenberg Bank Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $45.74
- TD Cowen Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $44 正面
- Berenberg Bank Downgrades Qiagen NV(QGEN.US) to Hold Rating, Cuts Target Price to $45.56 负面
- J.P. Morgan Maintains Qiagen NV(QGEN.US) With Buy Rating
- William Blair Initiates Qiagen NV(QGEN.US) With Hold Rating
- Jefferies Maintains Qiagen NV(QGEN.US) With Buy Rating, Announces Target Price $46
暂无评论——快来第一个聊聊 QGEN。
登录后参与讨论。